Process for making a pharmaceutical composition, comprising: a compound of formula (1) in crystalline form: ##STR00001## together with a pharmaceutically acceptable carrier or excipient,wherein the compound of formula (1) is present in polymorphic crystal form A substantially free of other polymorphs, and methods for making this polymorph.